Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin plasma exchange plus intravenous immunoglobulin for mild to moderate Alzheimer's disease
2011-001598-25Phase 3Completed
- Sponsor
- Instituto Grifols
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of albumin (human) and immune globulin in Alzheimer's disease (AD) (2 arms), sponsored by Instituto Grifols. Primary endpoint: Change from baseline in ADAS-Cog score. Started Aug 2011; status: completed.
02
Drugs
albumin (human)immune globulin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2011-001598-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001598-25.